Altering Intensive Care Sedation Paradigms to Improve Patient Outcomes

Critical Care Clinics

Volumn 25, Issue 3, 2009, Pages 527-538

  Riker, Richard R ^a,b   Fraser, Gilles L ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MAINE MEDICAL CENTER   (United States)

Author keywords

Adults; Analgesia; Critical care; Delirium; Outcomes; Sedation

Indexed keywords

CLONIDINE; CYTOCHROME P450 3A4; DEXMEDETOMIDINE; FENTANYL; FLUCONAZOLE; LORAZEPAM; MIDAZOLAM; MORPHINE; PROPOFOL; PROPYLENE GLYCOL; REMIFENTANIL;

ANALGESIA; ARTIFICIAL VENTILATION; BRADYCARDIA; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTINUOUS INFUSION; DELIRIUM; DRUG ACCUMULATION; DRUG ELIMINATION; DRUG METABOLISM; DRUG SAFETY; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY INJURY; MEMORY DISORDER; METABOLIC ACIDOSIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PANCREATITIS; PATIENT MONITORING; PRIORITY JOURNAL; RELIABILITY; RESPIRATION DEPRESSION; REVIEW; SEDATION; SIDE EFFECT; SURVIVAL; TACHYCARDIA; TREATMENT DURATION;

ANALGESIA; ANTI-ANXIETY AGENTS; CONSCIOUS SEDATION; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; INTENSIVE CARE UNITS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL;

EID: 67649306400     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.05.004     Document Type: Review

References (65)

1. Ramsay M.A., Savege T.M., Simpson B.R., et al. Controlled sedation with alphaxalone-alphadolone. Br Med J 2 5920 (1974) 656-659
2. Merriman H.M. The techniques used to sedate ventilated patients. A survey of methods used in 34 ICUs in Great Britain. Intensive Care Med 7 5 (1981) 217-224
3. Simpson P.J., and Eltringham R.J. Lorazepam in intensive care. Clin Ther 4 3 (1981) 150-163
4. Edbrooke D.L., Newby D.M., Mather S.J., et al. Safer sedation for ventilated patients. A new application for etomidate. Anaesthesia 37 7 (1982) 765-771
5. Ledingham I.M., and Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1 8336 (1983) 1270
6. Parker M.M., Schubert W., Shelhamer J.H., et al. Perceptions of a critically ill patient experiencing therapeutic paralysis in an ICU. Crit Care Med 12 1 (1984) 69-71
7. Ball M., McQuay H.J., Moore R.A., et al. Renal failure and the use of morphine in intensive care. Lancet 1 8432 (1985) 784-786
8. Shapiro J.M., Westphal L.M., White P.F., et al. Midazolam infusion for sedation in the intensive care unit: effect on adrenal function. Anesthesiology 64 3 (1986) 394-398
9. Grounds R.M., Lalor J.M., Lumley J., et al. Propofol infusion for sedation in the intensive care unit: preliminary report. Br Med J (Clin Res Ed) 294 6569 (1987) 397-400
10. Geller E., Halpern P., Barzelai E., et al. Midazolam infusion and the benzodiazepine antagonist flumazenil for sedation of intensive care patients. Resuscitation 16 Suppl (1988) S31-S39
11. Segredo V., Matthay M.A., Sharma M.L., et al. Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. Anesthesiology 72 3 (1990) 566-570
12. Shapiro B.A., Warren J., Egol A.B., et al. Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: an executive summary. Crit Care Med 23 9 (1995) 1596-1600
13. Jacobi J., Fraser G.L., Coursin D.B., et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30 1 (2002) 119-141
14. Rhoney D.H., and Murry K.R. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med 18 3 (2003) 139-145
15. Patel R.P., Gambrell M., Speroff T., et al. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med 37 3 (2009) 825-832
16. Martin J., Franck M., Sigel S., et al. Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care 11 6 (2007) R124
17. Martin J., Franck M., Fischer M., et al. Sedation and analgesia in German intensive care units: how is it done in reality? Results of a patient-based survey of analgesia and sedation. Intensive Care Med 32 8 (2006) 1137-1142
18. Shehabi Y., Botha J.A., Boyle M.S., et al. Sedation and delirium in the intensive care unit: an Australian and New Zealand perspective. Anaesth Intensive Care 36 (2008) 1-9
19. Mehta S., Burry L., Fischer S., et al. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 34 2 (2006) 374-380
20. Mehta S., Meade M.O., Hynes P., et al. A multicenter survey of Ontario intensive care unit nurses regarding the use of sedatives and analgesics for adults receiving mechanical ventilation. J Crit Care 22 3 (2007) 191-196
21. Riker R.R., Picard J.T., and Fraser G.L. Prospective evaluation of the sedation-agitation scale in adult ICU patients. Crit Care Med 27 (1999) 1325-1329
22. Sessler C.N., Gosnell M.S., Grap M.J., et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 166 10 (2002) 1338-1344
23. Ely E.W., Margolin R., Francis J., et al. Evaluation of delirium in critically ill patients: validation of the confusion assessment method for the intensive care unit (CAM-ICU). Crit Care Med 29 7 (2001) 1370-1379
24. Ely E.W., Inouye S.K., Bernard G.R., et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 286 21 (2001) 2703-2710
25. Bergeron N., Dubois M.J., Dumont M., et al. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 27 5 (2001) 859-864
26. Devlin J.W., Fong J.J., Schumaker G., et al. Use of a validated delirium assessment tool improves the ability of physicians to identify delirium in medical intensive care unit patients. Crit Care Med 35 12 (2007) 2721-2724
27. Puntillo K.A., White C., Morris A.B., et al. Patients' perceptions and responses to procedural pain: results from Thunder Project II. Am J Crit Care 10 4 (2001) 238-251
28. Gélinas C. Management of pain in cardiac surgery ICU patients: have we improved over time?. Intensive Crit Care Nurs 23 5 (2007) 298-303
29. Breen D., Karabinis A., Malbrain M., et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial. Crit Care 9 3 (2005) R200-R210
30. Dahaba A.A., Grabner T., Rehak P.H., et al. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology 101 3 (2004) 640-646
31. Muellejans B., Lopez A., Cross M.H., et al. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized double-blind controlled trial. Critical Care 8 (2004) R1-R11
32. Rozendaal F.W., Spronk P.E., Snellen F.F., et al. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med 35 (2008) 291-298
33. Muellejans B., Matthey T., Scholpp J., et al. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomized, open-label, pharmacoeconomic trial. Critical Care 10 (2006) R91
34. Bauer T.M., Ritz R., Haberthür C., et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 346 8968 (1995) 145-147
35. Spina S.P., and Ensom M.H. Clinical pharmacokinetic monitoring of midazolam in critically ill patients. Pharmacotherapy 27 3 (2007) 389-398
36. Yahwak J.A., Riker R.R., Fraser G.L., et al. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy 28 (2008) 984-991
37. Nelsen J.L., Haas C.E., Habtemariam B., et al. A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients. J Intensive Care Med 23 3 (2008) 184-194
38. Pandharipande P.P., Pun B.T., Herr D.L., et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 298 22 (2007) 2644-2653
39. Pandharipande P., Shintani A., Peterson J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104 1 (2006) 21-26
40. Pandharipande P., Cotton B.A., Shintani A., et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 65 1 (2008) 34-41
41. Mallow Corbett S., Montoya I.D., and Moore F.A. Propofol-related infusion syndrome in intensive care patients. Pharmacotherapy 28 2 (2008) 250-258
42. Kam P.C.A., and Cardone D. Propofol infusion syndrome. Anaesthesia 62 (2007) 690-701
43. Fong J.J., Sylvia L., Ruthazer R., et al. Predictors of mortality in patients with suspected propofol infusion syndrome. Crit Care Med 36 (2008) 2281-2287
44. Riker R.R., Shehabi Y., Bokesch P.M., et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 301 5 (2009) 489-499
45. Maldonado J, Wysong A, van der Starre P, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics, in press.
46. Ruokonen E., Parviainen I., Jakob S.M., et al. Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 35 2 (2009) 282-290
47. Riker R., Shehabi Y., Pencina M., et al. Economic impact of dexmedetomidine vs midazolam in adult ICU patients with prolonged mechanical ventilation: an economic model. Crit Care Medicine 36 12 (2008) A17
48. Dasta J.F., Jacobi J., Sesti A.M., et al. Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis. Pharmacotherapy 26 6 (2006) 798-805
49. Gélinas C., Fillion L., Puntillo K.A., et al. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care 15 4 (2006) 420-427
50. Payen J.F., Bru O., Bosson J.L., et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 29 12 (2001) 2258-2263
51. Hopkins R.O., and Jackson J.C. Long-term neurocognitive function after critical illness. Chest 130 3 (2006) 869-878
52. Milbrandt E.B., and Angus D.C. Bench-to-bedside review: critical illness-associated cognitive dysfunction-mechanisms, markers, and emerging therapeutics. Crit Care 10 6 (2006) 238
53. Bergbom-Engberg I., and Haljamäe H. Assessment of patients' experience of discomforts during respiratory therapy. Crit Care Med 17 10 (1989) 1068-1072
54. Kanazawa H., Okada A., Igarashi E., et al. Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography-mass spectrometry. J Chromatogr A 1031 1-2 (2004) 213-218
55. Laine G.A., Hossain S.M., Solis R.T., et al. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother 29 11 (1995) 1110-1114
56. Seay R.E., Graves P.J., and Wilkin M.K. Comment: possible toxicity from propylene glycol in lorazepam infusion. Ann Pharmacother 31 5 (1997) 647-648
57. Reynolds H.N., Teiken P., Regan M.E., et al. Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion. Crit Care Med 28 5 (2000) 1631-1634
58. Merz T.M., Regli B., Rothen H.U., et al. Propofol infusion syndrome-a fatal case at a low infusion rate. Anesth Analg 103 4 (2006) 1050
59. Chukwuemeka A., Ko R., and Ralph-Edwards A. Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anaesth Intensive Care 34 5 (2006) 651-655
60. Herr D.L., Sum-Ping S.T.J., and England M. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 17 5 (2003) 576-584
61. Peterson J.F., Pun B.T., Dittus R.S., et al. Delirium and its motoric subtypes: a study of 614 critically ill patients. J Am Geriatr Soc 54 3 (2006) 479-484
62. Girard T.D., Kress J.P., Fuchs B.D., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 371 9607 (2008) 126-134
63. Kress J.P., Pohlman A.S., O'Connor M.F., et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342 20 (2000) 1471-1477
64. Brook A.D., Ahrens T.S., Schaiff R., et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27 12 (1999) 2609-2615
65. Jones C., Griffiths R.D., Slater T., et al. Significant cognitive dysfunction in non-delirious patients identified during and persisting following critical illness. Intensive Care Med 32 6 (2006) 923-926